More time with the dogs we love
Loyal is a clinical-stage veterinary medicine company developing drugs to extend the healthspan and lifespan of dogs. Its pipeline includes LOY-001, LOY-002, and LOY-003 targeting metabolic dysfunction and IGF-1 overexpression in aging and large-breed dogs. The company has enrolled over 1,300 senior dogs in its pivotal clinical study and has cleared key FDA milestones toward conditional approval.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountUnknown
Unknown
Unknown
Unknown
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
